These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37477904)

  • 21. Arginine-assembly as NO nano-donor prevents the negative feedback of macrophage repolarization by mitochondrial dysfunction for cancer immunotherapy.
    Zheng X; Liu Y; Liu Y; Zang J; Wang K; Yang Z; Chen N; Sun J; Huang L; Li Y; Xue L; Zhi H; Zhang X; Yu M; Chen S; Dong H; Li Y
    Biomaterials; 2024 Apr; 306():122474. PubMed ID: 38271788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-associated macrophage membrane-camouflaged pH-responsive polymeric micelles for combined cancer chemotherapy-sensitized immunotherapy.
    Du T; Wang Y; Luan Z; Zhao C; Yang K
    Int J Pharm; 2022 Aug; 624():121911. PubMed ID: 35700870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosome-mediated delivery of transforming growth factor-β receptor 1 kinase inhibitors and toll-like receptor 7/8 agonists for combination therapy of tumors.
    Lee JH; Song J; Kim IG; You G; Kim H; Ahn JH; Mok H
    Acta Biomater; 2022 Mar; 141():354-363. PubMed ID: 35007784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of thermosensitive resiquimod-loaded liposomes for enhanced cancer immunotherapy.
    Zhang H; Tang WL; Kheirolomoom A; Fite BZ; Wu B; Lau K; Baikoghli M; Raie MN; Tumbale SK; Foiret J; Ingham ES; Mahakian LM; Tam SM; Cheng RH; Borowsky AD; Ferrara KW
    J Control Release; 2021 Feb; 330():1080-1094. PubMed ID: 33189786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sono-Immunotherapy Mediated Controllable Composite Nano Fluorescent Probes Reprogram the Immune Microenvironment of Hepatocellular Carcinoma.
    Chen Y; Wu B; Shang H; Sun Y; Tian H; Yang H; Wang C; Wang X; Cheng W
    Int J Nanomedicine; 2023; 18():6059-6073. PubMed ID: 37908671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chitosan-Poly(Acrylic Acid) Nanoparticles Loaded with R848 and MnCl
    Liu X; Xu Y; Yin L; Hou Y; Zhao S
    Int J Nanomedicine; 2021; 16():5675-5692. PubMed ID: 34456564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential acid/reduction response of triblock copolymeric nanomicelles to release camptothecin and toll-like receptor 7/8 agonist for orchestrated chemoimmunotherapy.
    Ge X; Hao Y; Li H; Zhao H; Liu Y; Liu Y; Li X; Chen H; Zou J; Zhang S; Huang L; Shan G; Zhang Z
    J Nanobiotechnology; 2022 Aug; 20(1):369. PubMed ID: 35953798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lyophilizable and Multifaceted Toll-like Receptor 7/8 Agonist-Loaded Nanoemulsion for the Reprogramming of Tumor Microenvironments and Enhanced Cancer Immunotherapy.
    Kim SY; Kim S; Kim JE; Lee SN; Shin IW; Shin HS; Jin SM; Noh YW; Kang YJ; Kim YS; Kang TH; Park YM; Lim YT
    ACS Nano; 2019 Nov; 13(11):12671-12686. PubMed ID: 31589013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
    Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
    Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of Adamantane-Conjugated TLR7/8 Agonists for Supramolecular Delivery and Cancer Immunotherapy.
    Rodell CB; Ahmed MS; Garris CS; Pittet MJ; Weissleder R
    Theranostics; 2019; 9(26):8426-8436. PubMed ID: 31879528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-drug conjugates self-assembled nanomedicines triggered photo-/immuno- therapy for synergistic cancer treatments.
    Qu H; Li L; Chen H; Tang M; Cheng W; Lin TY; Li L; Li B; Xue X
    J Control Release; 2023 Nov; 363():361-375. PubMed ID: 37751826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Injectable alginate hydrogels for synergistic tumor combination therapy through repolarization of tumor-associated macrophages.
    Xiao T; Zhu J; Jia L; Che H; Liu J; Deckers J; van Hest JCM; Shi X
    J Control Release; 2022 Aug; 348():239-249. PubMed ID: 35660633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein-Crowned Micelles for Targeted and Synergistic Tumor-Associated Macrophage Reprogramming to Enhance Cancer Treatment.
    Sun JH; Liang X; Cai M; Yan L; Chen Z; Guo L; Jing L; Wang Y; Zhou D
    Nano Lett; 2022 Jun; 22(11):4410-4420. PubMed ID: 35575719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel anti-CD47 protein antibody and toll-like receptor agonist complex detects tumor surface CD-47 changes in early stage lung cancer by in vivo imaging.
    Xu Y; Gu L; Zhu L; Miao Y; Cui X
    Int J Biol Macromol; 2024 Aug; 274(Pt 1):133322. PubMed ID: 38908646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoscale coordination polymer synergizes photodynamic therapy and toll-like receptor activation for enhanced antigen presentation and antitumor immunity.
    Jiang X; Liu J; Lee MJ; Peng C; Luo T; Tillman L; Weichselbaum RR; Lin W
    Biomaterials; 2023 Nov; 302():122334. PubMed ID: 37776767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 37. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
    Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
    Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy.
    Huang L; Xu R; Li W; Lv L; Lin C; Yang X; Yao Y; Saw PE; Xu X
    Acta Biomater; 2023 May; 162():98-109. PubMed ID: 36931417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor Acidic Microenvironment-Responsive Promodulator Iron Oxide Nanoparticles for Photothermal-Enhanced Chemodynamic Immunotherapy of Cancer.
    Chen S; Lv Y; Wang Y; Kong D; Xia J; Li J; Zhou Q
    ACS Biomater Sci Eng; 2023 Feb; 9(2):773-783. PubMed ID: 36598463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Light and immunostimulant mediated
    Uthaman S; Pillarisetti S; Lim YM; Jeong JO; Bardhan R; Huh KM; Park IK
    Biomater Sci; 2022 Dec; 11(1):298-306. PubMed ID: 36448579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.